Suppliers / Chieron Active Ingredients

Chieron Active Ingredients

India Updated 9 July 2026

Chieron Active Ingredients is an API manufacturer based in India. It holds 14 active US drug master files across a filed portfolio of 11 molecules. Its most recent recorded inspection, by US FDA, closed on 15 November 2019 as VAI. Customs aggregates show $4.0M of exports covering 120 molecules to 31 destinations in 2025.

14
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 15 November 2019 VAI US FDA
  • 9 June 2017 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Spsr Nellore, India 3006897905

What they file, and where

Molecule Regulators Docs
Olmesartan US FDA 2
Tetracaine US FDA 2
Warfarin US FDA 2
Dapagliflozin US FDA 1
Lacosamide US FDA 1
Levetiracetam US FDA 1
Linagliptin US FDA 1
Risperidone US FDA 1
Rivaroxaban US FDA 1
Sitagliptin US FDA 1
Show all 11 molecules on file
Vildagliptin US FDA 1

Also appears on these molecule pages

Lacosamide API Risperidone API Tetracaine API Vildagliptin API Warfarin API Sitagliptin API Levetiracetam API Dapagliflozin API Linagliptin API Rivaroxaban API Olmesartan API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $2.5M 17
2025 Not reported $4.0M 31

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Chieron Active Ingredients

Does Chieron Active Ingredients hold a US DMF or a CEP?
Chieron Active Ingredients holds 14 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Chieron Active Ingredients FDA-registered?
One site operated by Chieron Active Ingredients carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Chieron Active Ingredients's last inspection go?
The most recent inspection on record closed on 15 November 2019 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Chieron Active Ingredients manufacture?
1 registered site is on record, in India (Spsr Nellore). Every site is listed on this page with the register it came from.
What does Chieron Active Ingredients make?
11 molecules are on record against Chieron Active Ingredients, including Olmesartan, Tetracaine, Warfarin and Dapagliflozin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Chieron Active Ingredients comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 15 November 2019.

Comparable suppliers

Alembic Pharmaceuticals shares 3 molecules Zydus Lifesciences shares 3 molecules Apitoria Pharma shares 2 molecules Ipca Laboratories shares 2 molecules Jubilant Biosys shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts